Immune Systems

Emerging treatments & clinical trials based on how immune systems affect the development of mesothelioma cell types. Get up to date analysis.

Asbestos | Australia | Immune Systems | Immunotherapy | International | Mesothelioma | Prognosis | Research | Treatments

MicroRNAs May Be Key to Better Immunotherapy for Mesothelioma
ByAlex Strauss June 23, 2017

Australian scientists say it may be possible to artificially reduce the levels of a protein that helps mesothelioma tumors hide…

Read More MicroRNAs May Be Key to Better Immunotherapy for Mesothelioma
Alternatives | Immune Systems | Immunotherapy | Multi-Modality Therapy | Prognosis | Research | Treatments | Virus

Altered Viruses May Help Boost Immunotherapy for Malignant Mesothelioma
ByAlex Strauss May 31, 2017

Viruses may soon be playing a bigger role in the fight against malignant mesothelioma and other thoracic cancers. A pair…

Read More Altered Viruses May Help Boost Immunotherapy for Malignant Mesothelioma
Immune Systems | Immunotherapy | Multi-Modality Therapy | New Studies | Radiation Therapy | Research

Immunotherapy and Radiation: A Powerful Mesothelioma Combo
ByAlex Strauss May 23, 2017March 1, 2018

New research suggests that, in the battle against malignant pleural mesothelioma, a treatment combining immunotherapy drugs with radiotherapy may be a powerful…

Read More Immunotherapy and Radiation: A Powerful Mesothelioma Combo
Immune Systems | Immunotherapy | New Drugs | New Studies | Research | Treatments

MS Drug May Help Treat Malignant Mesothelioma, Too
ByAlex Strauss April 8, 2017May 10, 2017

Preliminary tests of a potential new mesothelioma treatment have yielded some exciting results at the University of Hawaii Cancer Center.…

Read More MS Drug May Help Treat Malignant Mesothelioma, Too
Alternatives | Biological Therapy | Immune Systems | Immunotherapy | Research | Treatments

The Key to Mesothelioma Treatment Success with Immunotherapy
ByAlex Strauss April 2, 2017May 10, 2017

Researchers with a biotechnology company that makes antibody-drug conjugates (ADC) for hard-to-treat cancers like malignant mesothelioma say careful patient selection…

Read More The Key to Mesothelioma Treatment Success with Immunotherapy
Asia | Holistic | Immune Systems | International | Prognosis | Research | Symptoms | Treatments

The Impact of Nutritional Status on Mesothelioma Survival
ByAlex Strauss March 12, 2017March 16, 2017

There is new evidence that a mesothelioma patient’s nutritional status could have an impact on their treatment outcomes. A group…

Read More The Impact of Nutritional Status on Mesothelioma Survival
Europe | Immune Systems | Immunotherapy | International | Multi-Modality Therapy | Research | Treatments | Updates

Immunotherapy for Pleural Mesothelioma: Does it Work?
ByAlex Strauss February 27, 2017March 16, 2017

Immunotherapy is an important emerging therapeutic strategy for several types of cancer, but the jury is still out on whether…

Read More Immunotherapy for Pleural Mesothelioma: Does it Work?
Europe | Immune Systems | Immunotherapy | International | New Drugs | Research | Treatments | Updates

Immunotherapy Drug May Be New Option for Recurrent Mesothelioma
ByAlex Strauss December 16, 2016March 16, 2017

There may be new hope for malignant mesothelioma patients whose cancer recurs after treatment. A presentation at the recent World…

Read More Immunotherapy Drug May Be New Option for Recurrent Mesothelioma
Asbestos | Asia | Immune Systems | International | Mesothelioma | Research | Updates

Asbestos-Related T-Cell Changes Help Explain Mesothelioma Development
ByAlex Strauss November 28, 2016March 16, 2017

Researchers in Japan have taken another step toward understanding how asbestos causes malignant mesothelioma. Exposure to airborne asbestos fibers is…

Read More Asbestos-Related T-Cell Changes Help Explain Mesothelioma Development
Asbestos | Chemotherapy | Immune Systems | Immunotherapy | New Studies | Research | Treatments | Updates

New Mesothelioma Immunotherapies Target Key Protein
ByAlex Strauss November 25, 2016March 16, 2017

The cell-surface glycoprotein mesothelin is poised to be a key part of several new immunotherapy approaches for the treatment of…

Read More New Mesothelioma Immunotherapies Target Key Protein

1 (888) 378-1331

Immune Systems

MicroRNAs May Be Key to Better Immunotherapy for Mesothelioma

Altered Viruses May Help Boost Immunotherapy for Malignant Mesothelioma

Immunotherapy and Radiation: A Powerful Mesothelioma Combo

MS Drug May Help Treat Malignant Mesothelioma, Too

The Key to Mesothelioma Treatment Success with Immunotherapy

The Impact of Nutritional Status on Mesothelioma Survival

Immunotherapy for Pleural Mesothelioma: Does it Work?

Immunotherapy Drug May Be New Option for Recurrent Mesothelioma

Asbestos-Related T-Cell Changes Help Explain Mesothelioma Development

New Mesothelioma Immunotherapies Target Key Protein

United States Sources

Centers for Disease Control and Prevention (CDC), UNITED STATES

Creighton University School of Medicine, UNITED STATES

David Geffen School of Medicine, UCLA, UNITED STATES

Icahn School of Medicine at Mount Sinai, New York, UNITED STATES

Mayo Clinic, UNITED STATES

Moffitt Cancer Center, Tampa, FL, UNITED STATES

National Institute for Occupational Safety & Health, UNITED STATES

University of Chicago, Medical Center, UNITED STATES

University of Maryland School of Medicine, UNITED STATES

University of Hawaii Cancer Center, UNITED STATES

Wake Forest University School of Medicine, UNITED STATES